ALEC
Price
$5.01
Change
-$0.26 (-4.93%)
Updated
Nov 5, 04:50 PM (EDT)
7 days until earnings call
RCUS
Price
$15.29
Change
-$0.27 (-1.74%)
Updated
Nov 5, 04:00 PM (EDT)
One day until earnings call
Ad is loading...

ALEC vs RCUS

Header iconALEC vs RCUS Comparison
Open Charts ALEC vs RCUSBanner chart's image
Alector
Price$5.01
Change-$0.26 (-4.93%)
Volume$200
CapitalizationN/A
Arcus Biosciences
Price$15.29
Change-$0.27 (-1.74%)
Volume$46.04K
CapitalizationN/A
View a ticker or compare two or three
ALEC vs RCUS Comparison Chart
Loading...
ALEC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RCUS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ALEC vs. RCUS commentary
Nov 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALEC is a Hold and RCUS is a Hold.

COMPARISON
Comparison
Nov 05, 2024
Stock price -- (ALEC: $5.27 vs. RCUS: $15.56)
Brand notoriety: ALEC and RCUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALEC: 240% vs. RCUS: 88%
Market capitalization -- ALEC: $488.55M vs. RCUS: $1.42B
ALEC [@Biotechnology] is valued at $488.55M. RCUS’s [@Biotechnology] market capitalization is $1.42B. The market cap for tickers in the [@Biotechnology] industry ranges from $498.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALEC’s FA Score shows that 0 FA rating(s) are green whileRCUS’s FA Score has 0 green FA rating(s).

  • ALEC’s FA Score: 0 green, 5 red.
  • RCUS’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALEC and RCUS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALEC’s TA Score shows that 4 TA indicator(s) are bullish while RCUS’s TA Score has 5 bullish TA indicator(s).

  • ALEC’s TA Score: 4 bullish, 2 bearish.
  • RCUS’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, ALEC is a better buy in the short-term than RCUS.

Price Growth

ALEC (@Biotechnology) experienced а +3.94% price change this week, while RCUS (@Biotechnology) price change was -6.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +14.28%, and the average quarterly price growth was +9.90%.

Reported Earning Dates

ALEC is expected to report earnings on Apr 01, 2025.

RCUS is expected to report earnings on Feb 19, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCUS($1.42B) has a higher market cap than ALEC($489M). RCUS YTD gains are higher at: -18.534 vs. ALEC (-33.960). ALEC has higher annual earnings (EBITDA): -178.26M vs. RCUS (-235M). RCUS has more cash in the bank: 969M vs. ALEC (503M). RCUS has less debt than ALEC: RCUS (11M) vs ALEC (36.1M). RCUS has higher revenues than ALEC: RCUS (247M) vs ALEC (55.3M).
ALECRCUSALEC / RCUS
Capitalization489M1.42B34%
EBITDA-178.26M-235M76%
Gain YTD-33.960-18.534183%
P/E RatioN/AN/A-
Revenue55.3M247M22%
Total Cash503M969M52%
Total Debt36.1M11M328%
FUNDAMENTALS RATINGS
RCUS: Fundamental Ratings
RCUS
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
75
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALECRCUS
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 13 days ago
84%
Bearish Trend 6 days ago
81%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Ad is loading...
ALEC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RCUS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GMXAX17.570.05
+0.29%
Nationwide Mid Cap Market Idx A
JATNX67.570.09
+0.13%
Janus Henderson Glb Tech and Innovt N
RESGX17.740.02
+0.11%
Glenmede Environmental Accountability
GSTKX17.09N/A
N/A
Goldman Sachs International Eq Inc Inv
KCXIX17.63N/A
N/A
Knights of Columbus U.S. All Cap Idx I

ALEC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALEC has been loosely correlated with DNLI. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ALEC jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALEC
1D Price
Change %
ALEC100%
+4.98%
DNLI - ALEC
58%
Loosely correlated
+0.59%
NTLA - ALEC
55%
Loosely correlated
+2.30%
BEAM - ALEC
53%
Loosely correlated
+6.24%
RCKT - ALEC
52%
Loosely correlated
-0.91%
EDIT - ALEC
51%
Loosely correlated
-1.03%
More

RCUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with DNLI. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
+0.39%
DNLI - RCUS
50%
Loosely correlated
+0.59%
SNDX - RCUS
48%
Loosely correlated
-0.21%
PRME - RCUS
48%
Loosely correlated
-1.49%
PLRX - RCUS
47%
Loosely correlated
-0.14%
ALEC - RCUS
47%
Loosely correlated
+4.98%
More